Hall技术在随机试验中的成本效果分析
基于苏格兰一项为期5年的随机对照实践试验,对132名儿童264颗乳磨牙分别采用Hall技术(HT)或传统去腐充填(CR),从社会视角进行经济学分析。结果显示HT的牙齿存活率更高(99% vs 92%),且累积直接治疗成本和间接/机会成本均显著低于CR,表明HT更具成本效果。
要点
- HT组乳磨牙5年存活率99%(95%CI 98%–100%),显著高于CR组92%(87%–97%)。
- NHS苏格兰视角下HT累积直接治疗成本24 GBP(23–25),低于CR的29 GBP(17–46)。
- HT间接/机会成本8 GBP(7–9)显著低于CR的19 GBP(16–23),总累积成本HT更低。
核心结论
- 在长期实践试验中,Hall技术比传统去腐充填更具成本效果,牙齿保留更久、并发症更少且成本更低。
研究设计与样本
- 一项为期5年的随机对照实践试验,纳入132名儿童264颗乳磨牙,由17名全科牙医提供HT或CR治疗。
- 经济学分析采用社会视角,直接治疗成本基于苏格兰NHS视角,敏感性分析采用英格兰NHS视角,间接/机会成本基于英国视角。
主要发现
- HT组乳磨牙存活率99%(95%CI 98%–100%),显著高于CR组92%(95%CI 87%–97%)。
- HT组无疼痛且无需牙髓治疗/拔牙的牙齿比例显著高于CR组。
- NHS苏格兰视角下HT累积直接治疗成本24 GBP(95%CI 23–25),CR为29 GBP(95%CI 17–46)。
- NHS英格兰视角下HT成本优势更明显:HT 29 GBP(25–34) vs CR 107 GBP(86–127)。
- HT间接/机会成本8 GBP(7–9)显著低于CR的19 GBP(16–23);总累积成本HT 32 GBP(31–34)低于CR 49 GBP(34–69)。
关键数值与推荐
- 主要结局为牙齿存活;次要结局包括无疼痛且无需牙髓治疗/拔牙、无需再充填。
- 成本效果和可接受性通过自举样本估计。
临床怎么用
- 对于乳磨牙龋坏,Hall技术可作为传统去腐充填的成本效果更优的替代方案。
- HT在长期保留牙齿、减少并发症和降低治疗成本方面具有优势,适合在基层牙科实践中推广。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical and patient-reported outcomes were reported for carious primary molars treated with the Hall technique (HT) as compared with conventional carious tissue removal and restorations (i.e., conventional restoration [CR]) in a 5-y randomized controlled practice-based trial in Scotland. We interrogated this data set further to investigate the cost-effectiveness of HT versus CR. A total of 132 children who had 2 matched occlusal/occlusal-proximal carious lesions in primary molars ( n = 264 teeth) were randomly allocated to HT or CR, provided by 17 general dental practitioners. Molars were followed up for a mean 5 y. A societal perspective was taken for the economic analysis. Direct dental treatment costs were estimated from a Scottish NHS perspective (an NHS England perspective was taken for a sensitivity analysis). Initial, maintenance, and retreatment costs, including rerestorations, endodontic treatments, and extractions, were estimated with fee items. Indirect/opportunity costs were estimated with time and travel costs from a UK perspective. The primary outcome was tooth survival. Secondary outcomes included 1) not having pain or needing endodontic treatments/extractions and 2) not needing rerestorations. Cost-effectiveness and acceptability were estimated from bootstrapped samples. Significantly more molars in HT survived (99%, 95% CI: 98% to 100%) than in CR (92%; 87% to 97%). Also, the proportion of molars retained without pain or requiring endodontic treatment/extraction was significantly higher in HT than CR. In the base case analysis (NHS Scotland perspective), cumulative direct dental treatment costs (Great British pound [GBP]) of HT were 24 GBP (95% CI: 23 to 25); costs for CR were 29 (17 to 46). From an NHS England perspective, the cost advantage of HT (29 GBP; 95% CI: 25 to 34) over CR (107; 86 to 127) was more pronounced. Indirect/opportunity costs were significantly lower for HT (8 GBP; 95% CI: 7 to 9) than CR (19; 16 to 23). Total cumulative costs were significantly lower for HT (32 GBP; 95% CI: 31 to 34) than CR (49; 34 to 69). Based on a long-term practice-based trial, HT was more cost-effective than CR with HT retained for longer and experiencing less complications at lower costs.
引用
- Schwendicke F, Krois J, Robertson M, et al. Cost-effectiveness of the Hall Technique in a Randomized Trial. J Dent Res. 2018. PMID: 30216734. doi:10.1177/0022034518799742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。